165 related articles for article (PubMed ID: 21910810)
1. C-peptide in the classification of diabetes in children and adolescents.
Ludvigsson J; Carlsson A; Forsander G; Ivarsson S; Kockum I; Lernmark A; Lindblad B; Marcus C; Samuelsson U
Pediatr Diabetes; 2012 Feb; 13(1):45-50. PubMed ID: 21910810
[TBL] [Abstract][Full Text] [Related]
2. Proinsulin, GLP-1, and glucagon are associated with partial remission in children and adolescents with newly diagnosed type 1 diabetes.
Kaas A; Andersen ML; Fredheim S; Hougaard P; Buschard K; Petersen JS; de Beaufort C; Robertson KJ; Hansen L; Mortensen HB; Nielsen LB;
Pediatr Diabetes; 2012 Feb; 13(1):51-8. PubMed ID: 22118630
[TBL] [Abstract][Full Text] [Related]
3. Gender differences in GAD antibody-positive diabetes mellitus in relation to age at onset, C-peptide and other endocrine autoimmune diseases.
Lindholm E; Hallengren B; Agardh CD
Diabetes Metab Res Rev; 2004; 20(2):158-64. PubMed ID: 15037992
[TBL] [Abstract][Full Text] [Related]
4. [Clinical heterogeneity of childhood diabetes in Baranya county].
Makovi H; Soltész G; Hermann R
Orv Hetil; 2002 Nov; 143(44):2489-92. PubMed ID: 12674804
[TBL] [Abstract][Full Text] [Related]
5. Clinical manifestations and beta cell function in Swedish diabetic children have remained unchanged during the last 25 years.
Nordwall M; Ludvigsson J
Diabetes Metab Res Rev; 2008 Sep; 24(6):472-9. PubMed ID: 18613248
[TBL] [Abstract][Full Text] [Related]
6. Fasting c-peptide and insulin-like growth factor-binding protein-1 levels help to distinguish childhood type 1 and type 2 diabetes at diagnosis.
Katz LE; Jawad AF; Ganesh J; Abraham M; Murphy K; Lipman TH
Pediatr Diabetes; 2007 Apr; 8(2):53-9. PubMed ID: 17448127
[TBL] [Abstract][Full Text] [Related]
7. Classification of diabetes in patients with end-stage renal disease. Validation of clinical criteria according to fasting plasma C-peptide.
Benhamou PY; Marwah T; Balducci F; Zmirou D; Borgel F; Cordonnier D; Halimi S; Papoz L
Clin Nephrol; 1992 Nov; 38(5):239-44. PubMed ID: 1451336
[TBL] [Abstract][Full Text] [Related]
8. The role of C-peptide in the classification of diabetes mellitus.
Wright-Pascoe R; Mills J; Choo-Kang E; Morrison EY
West Indian Med J; 2000 Jun; 49(2):138-42. PubMed ID: 10948853
[TBL] [Abstract][Full Text] [Related]
9. Islet antibodies associated with pancreatic B-cell dysfunction at and 3 years after diagnosis of diabetes in subjects aged 35-64 years old: degree of impairment less severe than in those aged 0-34 years old.
Berger B; Borg H; Fernlund P; Stenström G; Sundkvist G
Diabet Med; 2006 Nov; 23(11):1180-5. PubMed ID: 17054592
[TBL] [Abstract][Full Text] [Related]
10. Incidence of type 1 and type 2 diabetes in adults and children in Kronoberg, Sweden.
Thunander M; Petersson C; Jonzon K; Fornander J; Ossiansson B; Torn C; Edvardsson S; Landin-Olsson M
Diabetes Res Clin Pract; 2008 Nov; 82(2):247-55. PubMed ID: 18804305
[TBL] [Abstract][Full Text] [Related]
11. A comparison of childhood and adult type I diabetes mellitus.
Karjalainen J; Salmela P; Ilonen J; Surcel HM; Knip M
N Engl J Med; 1989 Apr; 320(14):881-6. PubMed ID: 2648146
[TBL] [Abstract][Full Text] [Related]
12. GADA and islet cell antibodies in Romanian children and adolescents with diabetes mellitus.
Serban V; Enache A; Vlad A; Sima A; Roşu M; Roşca A; Drăghici C
Rom J Intern Med; 2004; 42(2):325-32. PubMed ID: 15529623
[TBL] [Abstract][Full Text] [Related]
13. Poor beta-cell function after the clinical manifestation of type 1 diabetes in children initially positive for islet cell specific autoantibodies. The Childhood Diabetes in Finland Study Group.
Komulainen J; Knip M; Lounamaa R; Vähäsalo P; Karjalainen J; Sabbah E; Akerblom HK
Diabet Med; 1997 Jul; 14(7):532-7. PubMed ID: 9223390
[TBL] [Abstract][Full Text] [Related]
14. Urinary C-Peptide/Creatinine Ratio Can Distinguish Maturity-Onset Diabetes of the Young from Type 1 Diabetes in Children and Adolescents: A Single-Center Experience.
Yılmaz Agladioglu S; Sagsak E; Aycan Z
Horm Res Paediatr; 2015; 84(1):54-61. PubMed ID: 25792383
[TBL] [Abstract][Full Text] [Related]
15. The utility of the C-peptide in the phenotyping of patients candidates for pancreas transplantation.
Esmatjes E; Fernández C; Rueda S; Nicolau J; Chiganer G; Ricart MJ; Junca E; Fernández-Cruz L
Clin Transplant; 2007; 21(3):358-62. PubMed ID: 17488385
[TBL] [Abstract][Full Text] [Related]
16. C-peptide and autoimmune markers in diabetes.
Törn C
Clin Lab; 2003; 49(1-2):1-10. PubMed ID: 12593469
[TBL] [Abstract][Full Text] [Related]
17. Type 2 diabetes mellitus among children and adolescents in Al-Ain: a case series.
Punnose J; Agarwal MM; Bin-Uthman S
East Mediterr Health J; 2005 Jul; 11(4):788-97. PubMed ID: 16700395
[TBL] [Abstract][Full Text] [Related]
18. Can Biomarkers Help Target Maturity-Onset Diabetes of the Young Genetic Testing in Antibody-Negative Diabetes?
Majidi S; Fouts A; Pyle L; Chambers C; Armstrong T; Wang Z; Batish SD; Klingensmith G; Steck AK
Diabetes Technol Ther; 2018 Feb; 20(2):106-112. PubMed ID: 29355436
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of the new ADA and WHO criteria for classification of diabetes mellitus in young adult people (15-34 yrs) in the Diabetes Incidence Study in Sweden (DISS).
Borg H; Arnqvist HJ; Björk E; Bolinder J; Eriksson JW; Nyström L; Jeppsson JO; Sundkvist G
Diabetologia; 2003 Feb; 46(2):173-81. PubMed ID: 12627315
[TBL] [Abstract][Full Text] [Related]
20. Association between age, IL-10, IFNγ, stimulated C-peptide and disease progression in children with newly diagnosed Type 1 diabetes.
Kaas A; Pfleger C; Kharagjitsingh AV; Schloot NC; Hansen L; Buschard K; Koeleman BP; Roep BO; Mortensen HB; Alizadeh BZ;
Diabet Med; 2012 Jun; 29(6):734-41. PubMed ID: 22150609
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
